AGIO
AgiosFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
12
U.S. public peers
Grade Position
Below peers
vs peer average
AGIO vs peer average
17/100
AGIO vs. peer average (F vs. C)
Grade spread
A 2 · B 4 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
12 graded
100% of tracked
Peer overview
ALNY is the first available peer comparator.
Mid-cap biotech with partnership-heavy strategy; comparable for BD outcomes and capital cadence.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AGIO
Agios
ALNY
Alnylam
Grade
F
B
Momentum
79
37
Value
41
60
Sentiment
0
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ALNY
AGIO / ALNY
Grade Position
Below peers
AGIO vs. peer average (F vs. C)
17/100
Momentum
79
AGIOValue
41
ALNYSentiment
0
ALNYRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AGIO
ALNY is the first peer returned for this comparison set.